uniQure receives EMA CHMP positive recommendation from CHMP for Glybera
20:51 EDT 20 Jul 2012 | News-Medical.net
uniQure announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion that recommends marketing authorization of Glybera (alipogene tiparvovec) as a treatment for lipoprotein..
Original Article: uniQure receives EMA CHMP positive recommendation from CHMP for Glybera
More From BioPortfolio on "uniQure receives EMA CHMP positive recommendation from CHMP for Glybera"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
